UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 326

Sortiert nach

Heparin-binding EGF-like growth factor is an early response gene to chemotherapy and contributes to chemotherapy resistance

Oncogene, 2007-03, Vol.26 (14), p.2006-2016

2007

Volltextzugriff (PDF)

Activation of EGFR by proteasome inhibition requires HB-EGF in pancreatic cancer cells

Oncogene, 2010-05, Vol.29 (21), p.3146-3152

2010

Volltextzugriff (PDF)

Concurrent chemotherapy inhibits herpes simplex virus-1 replication and oncolysis

Cancer gene therapy, 2013-02, Vol.20 (2), p.133-140

2013

Volltextzugriff (PDF)

Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression

Molecular and Cellular Biology, 1995-06, Vol.15 (6), p.3032-3040

1995

Volltextzugriff (PDF)

Expression of human α(1,3)fucosyltransferase antisense sequences inhibits selectin-mediated adhesion and liver metastasis of colon carcinoma cells

Cancer research (Chicago, Ill.), 1999-05, Vol.59 (9), p.2127-2135

1999

Volltextzugriff (PDF)

Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials

Current cancer drug targets, 2011-03, Vol.11 (3), p.254

2011

Volltextzugriff (PDF)

Fas and Fas ligand interactions in malignant disease

International journal of oncology, 2000-07, Vol.17 (1), p.5

2000

Volltextzugriff (PDF)

Phase I/II study of neoadjuvant bevacizumab, erlotinib and 5-fluorouracil with concurrent external beam radiation therapy in locally advanced rectal cancer

Annals of oncology, 2014-01, Vol.25 (1), p.121-126

2014

Volltextzugriff (PDF)

Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB

Nature medicine, 1999-04, Vol.5 (4), p.412-417

1999

Volltextzugriff (PDF)

Role of splenectomy in chronic lymphocytic leukemia

Journal of the American College of Surgeons, 1997-09, Vol.185 (3), p.237-243

1997

Volltextzugriff (PDF)

Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothecin (CPT-11) in colorectal cancer cells and a xenograft model is overcome by inhibition of nuclear factor-κB activation

Cancer research (Chicago, Ill.), 2000-05, Vol.60 (9), p.2323-2330

2000

Volltextzugriff (PDF)

Survival factors in 186 patients younger than 40 years old with colorectal adenocarcinoma

Journal of the American College of Surgeons, 1996-08, Vol.183 (2), p.105-112

1996

Volltextzugriff (PDF)

Managing unsuspected tumor invasion of the superior mesenteric-portal venous confluence during pancreaticoduodenectomy

The American journal of surgery, 1994, Vol.168 (4), p.352-354

1994

Volltextzugriff (PDF)

Immune Microenvironment in Sporadic Early-Onset versus Average-Onset Colorectal Cancer

Cancers, 2023-02, Vol.15 (5), p.1457

2023

Volltextzugriff (PDF)

Rationale for En Bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence

Annals of surgery, 1996-02, Vol.223 (2), p.154-162

1996

Volltextzugriff (PDF)

The influence of angiogenesis inhibitor AGM‐1470 on immune system status and tumor growth in vitro

International journal of cancer, 1993-10, Vol.55 (4), p.630-635

1993

Volltextzugriff (PDF)

NPI-0052 Enhances Tumoricidal Response to Conventional Cancer Therapy in a Colon Cancer Model

Clinical cancer research, 2006-11, Vol.12 (22), p.6758-6764

2006

Volltextzugriff (PDF)

Reactivation of murine tumour-infiltrating lymphocytes with solid-phase anti-CD3 antibody: in vitro cytokine production is associated with in vivo efficacy

Surgical oncology, 1994-04, Vol.3 (2), p.79-89

1994

Volltextzugriff (PDF)

Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341 : Implications for systemic nuclear factor-κB inhibition

Cancer research (Baltimore), 2001-05, Vol.61 (9), p.3535-3540

2001

Volltextzugriff (PDF)

Rationale for the treatment of solid tumors with the proteasome inhibitor bortezomib

Cancer treatment reviews, 2003-05, Vol.29, p.21-31

Cusack, James C.

2003

Volltextzugriff (PDF)

Vascular resection and intraoperative radiation therapy during pancreaticoduodenectomy: rationale and technique

Advances in surgery (Chicago), 1996, Vol.29, p.235-262

1996

Volltextzugriff (PDF)

PhaseI/II study of neoadjuvant bevacizumab, erlotinib and 5-fluorouracil with concurrent external beam radiation therapy in locally advanced rectal cancer

Annals of oncology, 2014, Vol.25 (1), p.121-126

2014

Volltextzugriff (PDF)

Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothe cin (CPT-11) in colorectal cancer cells and a xenograft model is overcome by inhibition of nuclear factor-kappaB activation

Cancer research (Chicago, Ill.), 2000-05, Vol.60 (9), p.2323-2330

2000

Volltextzugriff (PDF)

Enhancement of radiosensitivity by proteasome inhibition: Implications for a role of NF-κB

International journal of radiation oncology, biology, physics, 2001-05, Vol.50 (1), p.183-193

2001

Volltextzugriff (PDF)

Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition

Cancer research (Chicago, Ill.), 2001-05, Vol.61 (9), p.3535

2001

Volltextzugriff (PDF)

1 – 25 von 326

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(310)
Mit Volltextzugriff
(289)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Heparin-binding EGF-like growth factor is an early response gene to chemotherapy and contributes to chemotherapy resistance

Activation of EGFR by proteasome inhibition requires HB-EGF in pancreatic cancer cells

Concurrent chemotherapy inhibits herpes simplex virus-1 replication and oncolysis

Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression

Expression of human α(1,3)fucosyltransferase antisense sequences inhibits selectin-mediated adhesion and liver metastasis of colon carcinoma cells

Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials

Fas and Fas ligand interactions in malignant disease

Phase I/II study of neoadjuvant bevacizumab, erlotinib and 5-fluorouracil with concurrent external beam radiation therapy in locally advanced rectal cancer

Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB

Role of splenectomy in chronic lymphocytic leukemia

Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothecin (CPT-11) in colorectal cancer cells and a xenograft model is overcome by inhibition of nuclear factor-κB activation

Survival factors in 186 patients younger than 40 years old with colorectal adenocarcinoma

Managing unsuspected tumor invasion of the superior mesenteric-portal venous confluence during pancreaticoduodenectomy

Immune Microenvironment in Sporadic Early-Onset versus Average-Onset Colorectal Cancer

Rationale for En Bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence

The influence of angiogenesis inhibitor AGM‐1470 on immune system status and tumor growth in vitro

NPI-0052 Enhances Tumoricidal Response to Conventional Cancer Therapy in a Colon Cancer Model

Reactivation of murine tumour-infiltrating lymphocytes with solid-phase anti-CD3 antibody: in vitro cytokine production is associated with in vivo efficacy

Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341 : Implications for systemic nuclear factor-κB inhibition

Rationale for the treatment of solid tumors with the proteasome inhibitor bortezomib

Vascular resection and intraoperative radiation therapy during pancreaticoduodenectomy: rationale and technique

PhaseI/II study of neoadjuvant bevacizumab, erlotinib and 5-fluorouracil with concurrent external beam radiation therapy in locally advanced rectal cancer

Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothe cin (CPT-11) in colorectal cancer cells and a xenograft model is overcome by inhibition of nuclear factor-kappaB activation

Enhancement of radiosensitivity by proteasome inhibition: Implications for a role of NF-κB

Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition

Suchergebnisse filtern